II
PBYI icon

Inspire Investing’s Puma Biotechnology PBYI Stock Holding History

Inspire Investing’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$31 Hold
5
– – ﹤0.01% 1085
2025
Q4 		$31 Buy
+5
New +$27 ﹤0.01% 1088
2020
Q2 		– Sell
-41
Closed – – 655
2020
Q1 		$0 Sell
41
-21,350
-100% -$207K ﹤0.01% 778
2019
Q4 		$187K Buy
21,391
+5,494
+35% +$45.5K 0.07% 286
2019
Q3 		$171K Buy
15,897
+3,658
+30% +$39.5K 0.07% 360
2019
Q2 		$156K Buy
+12,239
New +$282K 0.07% 324
2018
Q1 		– Sell
-590
Closed -$58K – 551
2017
Q4 		$58K Buy
+590
New +$66K 0.05% 404

Other funds holding PBYI

ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Inspire Investing's PBYI Position: Q1 2026 in Review

Inspire Investing held its Puma Biotechnology (PBYI) position steady in Q1 2026 at 5 shares worth $31. The position accounts for ﹤0.01% of the portfolio, ranked #1085.

Inspire Investing first reported a position in PBYI in Q4 2017 and has held it in 7 quarters since. The position peaked at $187K in Q4 2019. 157 funds tracked by Wall St. Rank hold PBYI as of Q1 2026.

  • Inspire Investing held 5 shares of Puma Biotechnology worth $31 as of Q1 2026.
  • Inspire Investing left its Puma Biotechnology share count unchanged in Q1 2026.
  • Puma Biotechnology made up ﹤0.01% of Inspire Investing's portfolio in Q1 2026, its #1085 holding.
  • Inspire Investing first reported a position in Puma Biotechnology in Q4 2017 and has held it in 7 quarters since.
  • Inspire Investing's Puma Biotechnology position peaked at $187K in Q4 2019.
  • 157 funds tracked by Wall St. Rank held Puma Biotechnology as of Q1 2026.

Based on Inspire Investing's 13F filing for Q1 2026, filed 23 Apr 2026.